HOME >> BIOLOGY >> NEWS
Researchers discover 'acquired' DNA key to certain bacterial infection

CORVALLIS, Ore. -- Researchers announced this week the discovery of a mechanism by which Mycobacterium avium a bacterium which can result in serious lung infections and is prevalent in emphysema and AIDS patients among others infects tissue cells or macrophages and thus compromises the bodys immunity.

Results of the study, led by researchers at Oregon State University, will be published online this week in the Proceedings of the National Academy of Sciences. Other co-authors were from the University of Nebraska.

The key to the bacteriums ability to enter environmental amoebas and ultimately humans is an island of genetic material acquired through evolution from another bacterium, according to Luiz E. Bermudez, a professor of biomedical sciences in OSUs College of Veterinary Medicine and an author of the study.

Without these acquired genes, the bacterium is very inefficient in infecting environmental amoeba, which is the environmental host, Bermudez said. In fact, its efficiency is close to zero. But with this island of acquired genetic material, the bacterium finds a way to get inside the cells and it takes control, not the phagocyte.

Phagocytes are cells that engulf and digest pathogens and cellular debris, and in humans serve as the bodys initial immune response.

The researchers did not find a similar island of acquired genetic material in two similar bacteria, Mycobacterium tuberculosis and Mycobacterium paratuberculosis, which causes Johnes disease.

M. avium exists in the environment and is thought to infect humans when the infected environmental hosts amoebas are inhaled or swallowed.

Incidence of M. avium as a cause of syndromes may be decreasing because of changes in treatment for HIV-infected patients, according to the Centers for Disease Control and Prevention, which estimates that 1 out of 100,000 persons may be affected. However, CDC also notes that the bacteriums resistance
'"/>

Contact: Luiz Bermudez
luiz.bermudez@oregonstate.edu
541-737-6538
Oregon State University
18-Jun-2007


Page: 1 2

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers identify genetic mutation that may alter tumor cell proliferation
9. Researchers discover method for identifying how cancer evades the immune system
10. Researchers use adult stem cells to create soft tissue
11. Researchers find gene that spurs development of the epididymis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/8/2019)... ... May 08, 2019 , ... RG+A, Inc., a leading healthcare ... has agreed to serve as Chief Executive Officer and pharmaceutical leader Dr. Martin ... They will join Chairman and Founder Roger Green to create a three-person executive ...
(Date:5/8/2019)... ... 08, 2019 , ... FISO Technologies proudly presents the innovative ... lead-in fiber of 100 microns. With dimensions smaller than any competitive product, FISO ... world leader in the development of fiber optic sensors & signal conditioners used ...
(Date:5/2/2019)... ... , ... Philadelphia intellectual property law firm Panitch Schwarze ... a registered patent agent, has joined the firm as a new member of ... support and scientific expertise in the pharmaceutical and biotechnical arts and assists in ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... ... April 15, 2019 , ... Sirrus, Inc., a ... million bench plant expansion to increase production of methylene malonate monomers and oligomers. ... construction of Sirrus’ full-scale production facility, which is scheduled to break ground in ...
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life Sciences ... life sciences organizations to accelerate innovation and maximize productivity, announces that nearly 100 ... 12 months. , USDM’s Cloud Assurance is a managed subscription service ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced today ... with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test ... of the $1.7 million already awarded by CARB-X. The additional $1.7M will enable ...
Breaking Biology Technology:
Cached News: